These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 36879416)

  • 1. Oncolytic Virus-Driven Biotherapies from Bench to Bedside.
    Duan S; Wang S; Qiao L; Yu X; Wang N; Chen L; Zhang X; Zhao X; Liu H; Wang T; Wu Y; Li N; Liu F
    Small; 2023 Jun; 19(23):e2206948. PubMed ID: 36879416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging systemic delivery strategies of oncolytic viruses: A key step toward cancer immunotherapy.
    Ban W; Guan J; Huang H; He Z; Sun M; Liu F; Sun J
    Nano Res; 2022; 15(5):4137-4153. PubMed ID: 35194488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy.
    Wang X; Shen Y; Wan X; Hu X; Cai WQ; Wu Z; Xin Q; Liu X; Gui J; Xin HY; Xin HW
    J Transl Med; 2023 Jul; 21(1):500. PubMed ID: 37491263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of oncolytic virotherapy: from genetic modification to combination therapy.
    Lan Q; Xia S; Wang Q; Xu W; Huang H; Jiang S; Lu L
    Front Med; 2020 Apr; 14(2):160-184. PubMed ID: 32146606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas.
    Zeng J; Li X; Sander M; Zhang H; Yan G; Lin Y
    Front Immunol; 2021; 12():721830. PubMed ID: 34675919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiating oncolytic viruses by targeted drug intervention.
    Mahoney DJ; Stojdl DF
    Curr Opin Mol Ther; 2010 Aug; 12(4):394-402. PubMed ID: 20677090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic Viral Therapy in Osteosarcoma.
    Karadimas T; Huynh TH; Chose C; Zervoudakis G; Clampitt B; Lapp S; Joyce D; Letson GD; Metts J; Binitie O; Mullinax JE; Lazarides A
    Viruses; 2024 Jul; 16(7):. PubMed ID: 39066301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic vaccinia virus and cancer immunotherapy.
    Xu L; Sun H; Lemoine NR; Xuan Y; Wang P
    Front Immunol; 2023; 14():1324744. PubMed ID: 38283361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures.
    Schäfer TE; Knol LI; Haas FV; Hartley A; Pernickel SCS; Jády A; Finkbeiner MSC; Achberger J; Arelaki S; Modic Ž; Schröer K; Zhang W; Schmidt B; Schuster P; Haferkamp S; Doerner J; Gebauer F; Ackermann M; Kvasnicka HM; Kulkarni A; Bots STF; Kemp V; Hawinkels LJAC; Poetsch AR; Hoeben RC; Ehrhardt A; Marchini A; Ungerechts G; Ball CR; Engeland CE
    EBioMedicine; 2024 Jul; 105():105219. PubMed ID: 38941955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic Viruses as an Adjunct to Immune Checkpoint Inhibition.
    Ripp J; Hentzen S; Saeed A
    Front Biosci (Landmark Ed); 2022 May; 27(5):151. PubMed ID: 35638418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving systemic delivery of oncolytic viruses.
    Hill C; Carlisle R
    Expert Opin Drug Deliv; 2019 Jun; 16(6):607-620. PubMed ID: 31144549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of the efficacy of viro-immunotherapy: A review.
    de Graaf JF; Huberts M; Fouchier RAM; van den Hoogen BG
    Cytokine Growth Factor Rev; 2020 Dec; 56():124-132. PubMed ID: 32919831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical landscape of oncolytic virus research in 2020.
    Macedo N; Miller DM; Haq R; Kaufman HL
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33046622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes.
    Malogolovkin A; Gasanov N; Egorov A; Weener M; Ivanov R; Karabelsky A
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34209981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A call to arms: using RNAi screening to improve oncolytic viral therapy.
    Mahoney DJ; Stojdl DF
    Cytokine Growth Factor Rev; 2010; 21(2-3):161-7. PubMed ID: 20207578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses.
    Goradel NH; Alizadeh A; Hosseinzadeh S; Taghipour M; Ghesmati Z; Arashkia A; Negahdari B
    Future Oncol; 2022 Jan; 18(2):245-259. PubMed ID: 34821517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates to the antitumor mechanism of oncolytic virus.
    Bai Y; Hui P; Du X; Su X
    Thorac Cancer; 2019 May; 10(5):1031-1035. PubMed ID: 30900824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic virotherapies for pediatric tumors.
    Gross EG; Hamo MA; Estevez-Ordonez D; Laskay NM; Atchley TJ; Johnston JM; Markert JM
    Expert Opin Biol Ther; 2023; 23(10):987-1003. PubMed ID: 37749907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Oncolytic Herpes Simplex Virus 1 VC2 Promotes Long-Lasting, Systemic Anti-melanoma Tumor Immune Responses and Increased Survival in an Immunocompetent B16F10-Derived Mouse Melanoma Model.
    Uche IK; Fowlkes N; Vu L; Watanabe T; Carossino M; Nabi R; Del Piero F; Rudd JS; Kousoulas KG; Rider PJF
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33177208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic viruses: overcoming translational challenges.
    Martinez-Quintanilla J; Seah I; Chua M; Shah K
    J Clin Invest; 2019 Mar; 129(4):1407-1418. PubMed ID: 30829653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.